← Eichor
Study identifier: NCT02488876 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Database of Tissue Samples to Understand the Inflammatory Response After Cardiac Surgery

Condition: Heart Diseases  ·  Sponsor: RWTH Aachen University

PhaseN/A
Planned participants1000
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

The aim of this study is to collect non-individual related blood samples for the compelling of a unique database of tissue samples to understand the inflammatory responds after cardiac surgery on an on-going basis. This includes especially protein analyses and genetic testing for certain neurotransmitters in the blood and tissues to understand disease markers related to heart disease. The study is designed as an openly recruiting biobank with the purpose to later serve multiple study purposes. Outcomes refer to protein analyses and genetic testing for neurotransmitters in the blood and tissues.

This description comes directly from the study's public registry record.

Talk to the study team

Andreas Goetzenich, PD Dr. med.  ·  +49 241 80 35556  ·  agoetzenich@ukaachen.de

Christian Stoppe, PD Dr. med.  ·  +49 241 80 36575  ·  cstoppe@ukaachen.de

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital RWTH Aachen, Department of Thoracic and Cardiovascular SurgeryAachen, North Rhine-Westphalia, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02488876